About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
Cure Campus

Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Meet the Cure Team Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Events at the Cure

Stephen Anastos

Stephen Anastos is a Principal on the Healthcare Services team and joined the Firm in 2020 to focus on early and growth stage investments in healthcare technology and services companies. Prior to Deerfield, Mr. Anastos served on the Leadership Team of Medicaid in Massachusetts (MassHealth) and led MassHealth’s Accountable Care Organization program. Representing over $5 billion of annual spend and covering approximately 900,000 members, the ACO program is Massachusetts’ largest effort to transition the Medicaid delivery system towards value-based reimbursement. Before MassHealth, Mr. Anastos was a Principal at Bain Capital Ventures, where he worked on early and growth stage investments in healthcare, B2B software and consumer technology. In 2017, he was named to the Forbes 30 Under 30 list for Venture Capital. Prior to Bain, Mr. Anastos was an Associate at Blueprint Health, an incubator of digital health companies in New York, and began his career at Altman Vilandrie & Company, a technology-focused strategy consulting firm. He holds an A.B. in History with a minor in Economics from Harvard University, where he wrote his thesis on the creation of Medicare and Medicaid.